FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $617,355 | +41.5% | 139,044 | +5.1% | 0.00% | – |
Q2 2023 | $436,385 | +261.4% | 132,238 | +212.1% | 0.00% | – |
Q1 2023 | $120,754 | -71.2% | 42,370 | -26.5% | 0.00% | – |
Q4 2022 | $419,567 | +73.4% | 57,633 | +93.3% | 0.00% | – |
Q3 2022 | $242,000 | -52.4% | 29,818 | -71.2% | 0.00% | – |
Q2 2022 | $508,000 | +44.7% | 103,667 | +599.0% | 0.00% | – |
Q1 2022 | $351,000 | -29.1% | 14,831 | -47.0% | 0.00% | – |
Q4 2021 | $495,000 | +134.6% | 27,964 | +274.5% | 0.00% | – |
Q3 2021 | $211,000 | +95.4% | 7,468 | -27.3% | 0.00% | – |
Q2 2021 | $108,000 | +83.1% | 10,277 | +105.3% | 0.00% | – |
Q1 2021 | $59,000 | -70.4% | 5,005 | -70.5% | 0.00% | – |
Q4 2020 | $199,000 | +586.2% | 16,972 | +362.8% | 0.00% | – |
Q3 2020 | $29,000 | -90.3% | 3,667 | -77.5% | 0.00% | – |
Q2 2020 | $298,000 | +60.2% | 16,332 | +5.3% | 0.00% | – |
Q1 2020 | $186,000 | +500.0% | 15,514 | +739.0% | 0.00% | – |
Q4 2019 | $31,000 | +40.9% | 1,849 | -41.7% | 0.00% | – |
Q3 2019 | $22,000 | – | 3,170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |